home / stock / veru / veru news

VERU News and Press, Veru Inc.

Stock Information
Company Name: Veru Inc.
Stock Symbol: VERU
Market: NASDAQ
Website: verupharma.com
Menu
VERU VERU Quote VERU Short VERU News VERU Articles VERU Message Board
Get VERU Alerts

News, Short Squeeze, Breakout and More Instantly...
VERU - Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...
VERU - VERU Stock Earnings: Veru Beats EPS, Misses Revenue for Q1 2024

2024-06-26 07:53:05 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Veru (NASDAQ: VERU ) just reported results for the first quarter of 2024. Veru reported earnings per share of -8 cents. This was above the analyst estimate for EPS of -13 ...

VERU - Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024

MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...

VERU - Veru Reminds Shareholders to Vote in Advance of Tomorrow's Deadline for 2024 Annual Meeting of Shareholders

MIAMI, FL, June 17, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, would like to remi...
VERU - Veru to Present at the American Diabetes Association's 84th Scientific Sessions

MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...

VERU - Russell 3000: Veru, Life MD among consumer staple additions; Benson Hill, PetMed Express among deletions

2024-05-30 17:29:56 ET The Russell 3000 index will have a new look on June 28, after the market closes, when 225 securities will be added and 144 securities will be deleted as part of the annual reconstitution. Following are some notable consumer staples companies which will be ...

VERU - Veru to Present at the Jefferies Global Healthcare Conference

MIAMI, FL, May 22, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced tha...
VERU - Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced Ste...

VERU - Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week

MIAMI, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced tha...

VERU - Veru GAAP EPS of -$0.07 misses by $0.01, revenue of $4.14B beats by $4.14B

2024-05-08 06:33:25 ET More on Veru Veru Inc. (VERU) Q1 2024 Earnings Call Transcript Veru Q2 2024 Earnings Preview Veru gets Nasdaq notice related to delayed quarterly report on form 10-Q Seeking Alpha’s Quant Rating on Veru Historical earning...
Next 10